These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33928595)

  • 1. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
    Yang Y; Huang XJ
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3148. PubMed ID: 33928595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
    Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2462. PubMed ID: 33829425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
    Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3150. PubMed ID: 33928597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-146b-5p inhibits the malignant progression of gastric cancer by targeting TRAF6.
    Ding JN; Zang YF; Ding YL
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3151. PubMed ID: 33928598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
    Lei Y; Wang YH; Wang XF; Bai J
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2460. PubMed ID: 33829423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
    Tong WH; Mu JF; Zhang SP
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3398. PubMed ID: 34002807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0001982 accelerates the progression of colorectal cancer via sponging microRNA-144.
    Deng Q; Wang CJ; Hao R; Yang QY
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2458. PubMed ID: 33829421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
    Chen B; Zheng ZY; Yang JZ; Li XG
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3145. PubMed ID: 33928592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
    Wang J; Shu HZ; Xu CY; Guo SG
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10303. PubMed ID: 33155263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway.
    Jiang YL; Liu WW; Wang Y; Yang WY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):2. PubMed ID: 33506881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2158. PubMed ID: 33755947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10920. PubMed ID: 33215404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.
    Zang RK; Ma JB; Liang YC; Wang Y; Hu SL; Zhang Y; Dong W; Zhang W; Hu LK
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2457. PubMed ID: 33829426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2156. PubMed ID: 33755945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3.
    Jia XN; Yin SD; Wei Y; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7912. PubMed ID: 32767306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B.
    Ren R; Wu J; Zhou MY
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11469. PubMed ID: 33275209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.
    Shi XY; Wang H; Wang W; Gu YH
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10914. PubMed ID: 33215398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2159. PubMed ID: 33755958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9.
    Liu ZH; Liu WJ; Yu XY; Qi XL; Sun CC
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3798. PubMed ID: 35731047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.
    Mu Y; Liu WJ; Bie LY; Mu XQ; Zhao YQ
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3933. PubMed ID: 34156669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.